Evrofarma Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Evrofarma.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Food earnings growth | 10.1% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Subdued Growth No Barrier To Evrofarma SA (ATH:EVROF) With Shares Advancing 30%
Feb 29Evrofarma SA (ATH:EVROF) Stock Rockets 33% But Many Are Still Ignoring The Company
Jan 06Returns On Capital At Evrofarma (ATH:EVROF) Have Stalled
Jan 05Evrofarma (ATH:EVROF) Has A Somewhat Strained Balance Sheet
Dec 01Here's What's Concerning About Evrofarma's (ATH:EVROF) Returns On Capital
Sep 15Is Evrofarma (ATH:EVROF) Using Too Much Debt?
May 27We Think That There Are Issues Underlying Evrofarma's (ATH:EVROF) Earnings
Oct 04Returns On Capital At Evrofarma (ATH:EVROF) Paint A Concerning Picture
May 19Should Evrofarma SA (ATH:EVROF) Focus On Improving This Fundamental Metric?
Feb 22Be Wary Of Evrofarma (ATH:EVROF) And Its Returns On Capital
Dec 29Is Evrofarma SA's (ATH:EVROF) 2.2% ROE Worse Than Average?
Nov 22In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Evrofarma has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2023 | 49 | 3 | 0 | 3 | N/A |
3/31/2023 | 47 | 2 | 0 | 2 | N/A |
12/31/2022 | 45 | 1 | 0 | 2 | N/A |
9/30/2022 | 42 | 0 | -1 | 1 | N/A |
6/30/2022 | 39 | -1 | -3 | 0 | N/A |
3/31/2022 | 38 | -1 | -4 | 0 | N/A |
12/31/2021 | 37 | 0 | -4 | -1 | N/A |
9/30/2021 | 36 | 1 | -3 | -1 | N/A |
6/30/2021 | 36 | 1 | -2 | -1 | N/A |
3/31/2021 | 35 | 1 | -1 | 0 | N/A |
12/31/2020 | 34 | 1 | 1 | 1 | N/A |
9/30/2020 | 33 | 1 | 1 | 2 | N/A |
6/30/2020 | 32 | 0 | 2 | 2 | N/A |
3/31/2020 | 33 | 0 | 1 | 2 | N/A |
12/31/2019 | 33 | 0 | 1 | 2 | N/A |
9/30/2019 | 34 | 0 | 0 | 1 | N/A |
6/30/2019 | 35 | 1 | 0 | 1 | N/A |
3/31/2019 | 34 | 1 | 1 | 2 | N/A |
12/31/2018 | 33 | 1 | 1 | 2 | N/A |
9/30/2018 | 32 | 1 | 2 | 3 | N/A |
6/30/2018 | 31 | 1 | 2 | 3 | N/A |
3/31/2018 | 31 | 1 | 2 | 3 | N/A |
12/31/2017 | 31 | 1 | 2 | 3 | N/A |
9/30/2017 | 31 | 0 | 2 | 3 | N/A |
6/30/2017 | 30 | 0 | 2 | 3 | N/A |
3/31/2017 | 30 | 0 | N/A | 2 | N/A |
12/31/2016 | 29 | 0 | N/A | 1 | N/A |
9/30/2016 | 28 | 0 | N/A | 0 | N/A |
6/30/2016 | 28 | 0 | N/A | 1 | N/A |
3/31/2016 | 30 | 0 | N/A | 1 | N/A |
12/31/2015 | 30 | 1 | N/A | 1 | N/A |
9/30/2015 | 29 | 0 | N/A | 2 | N/A |
6/30/2015 | 28 | 0 | N/A | 2 | N/A |
3/31/2015 | 26 | 0 | N/A | 1 | N/A |
12/31/2014 | 25 | 0 | N/A | 1 | N/A |
9/30/2014 | 25 | 0 | N/A | 0 | N/A |
6/30/2014 | 25 | 0 | N/A | 0 | N/A |
3/31/2014 | 24 | 0 | N/A | 0 | N/A |
12/31/2013 | 23 | 0 | N/A | 0 | N/A |
9/30/2013 | 22 | -1 | N/A | 1 | N/A |
6/30/2013 | 22 | -2 | N/A | 1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if EVROF's forecast earnings growth is above the savings rate (2.4%).
Earnings vs Market: Insufficient data to determine if EVROF's earnings are forecast to grow faster than the Greek market
High Growth Earnings: Insufficient data to determine if EVROF's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if EVROF's revenue is forecast to grow faster than the Greek market.
High Growth Revenue: Insufficient data to determine if EVROF's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if EVROF's Return on Equity is forecast to be high in 3 years time